Serum metallothionein in patients with testicular cancer

[1]  K. Schmid,et al.  Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma , 2009, International Journal of Colorectal Disease.

[2]  F. Bray,et al.  Time trends in testicular cancer in Croatia 1983-2007: rapid increases in incidence, no declines in mortality. , 2012, Cancer epidemiology.

[3]  A. Russo,et al.  Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease , 2009, Drug, healthcare and patient safety.

[4]  N. Vasdev,et al.  Testicular Germ Cell Tumours - A European and UK Perspective , 2012 .

[5]  A. Timerbaev,et al.  Inductively coupled plasma mass spectrometry for metallodrug development: albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexes. , 2014, Journal of inorganic biochemistry.

[6]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[7]  F. Bray,et al.  Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality , 2006, International journal of cancer.

[8]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  W. Kim,et al.  High Lactate Dehydrogenase 5 Expression Correlates with High Tumoral and Stromal Vascular Endothelial Growth Factor Expression in Gastric Cancer , 2013, Pathobiology.

[10]  Lin‐feng Li,et al.  Lower Level 0f Serum Metallothionein I/II in Patients with Atopic Dermatitis , 2014 .

[11]  V. Adam,et al.  Serum metallothionein in newly diagnosed patients with childhood solid tumours. , 2010, Acta biochimica Polonica.

[12]  G. Casazza,et al.  Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review , 2006, The American Journal of Gastroenterology.

[13]  S Thameem Dheen,et al.  Metallothionein 2A expression is associated with cell proliferation in breast cancer. , 2002, Carcinogenesis.

[14]  Vojtech Adam,et al.  Utilizing of Adsorptive Transfer Stripping Technique Brdicka Reaction for Determination of Metallothioneins Level in Melanoma Cells, Blood Serum and Tissues , 2008, Sensors.

[15]  M. Nordberg,et al.  1:Metallothioneins: Historical Development and Overview , 2009 .

[16]  J. Chin,et al.  Metallothionein in testicular germ cell tumors and drug resistance: Clinical correlation , 1993, Cancer.

[17]  René Kizek,et al.  Employment of Electrochemical Techniques for Metallothionein Determination in Tumor Cell Lines and Patients with a Tumor Disease , 2008 .

[18]  M. Chatterjee,et al.  Metallothionein: an overview. , 2007, World journal of gastroenterology.

[19]  H. Pontes,et al.  Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  M. Čemažar,et al.  A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection. , 2013, Talanta.

[21]  V. Adam,et al.  Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker , 2011, Electrophoresis.

[22]  Biserka Raspor,et al.  Elucidation of the mechanism of the Brdička reaction , 2001 .

[23]  J. Wilson,et al.  Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck. , 1990, British journal of clinical pharmacology.

[24]  J. Goodisman,et al.  Kinetic study on the reaction of cisplatin with metallothionein. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[25]  I. Bodrogi,et al.  Do metallothioneins affect the response to treatment in testis cancers? , 1998, Journal of Cancer Research and Clinical Oncology.

[26]  G. Weinlich,et al.  Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients , 2006, British Journal of Cancer.

[27]  L. Paz-Ares,et al.  Biological markers of cisplatin resistance in advanced testicular germ cell tumours , 2008, Clinical and Translational Oncology.

[28]  B. Desoize,et al.  Particular aspects of platinum compounds used at present in cancer treatment. , 2002, Critical reviews in oncology/hematology.

[29]  B. Michalke.  Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs. , 2010, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[30]  Jaromír Hubálek,et al.  Study of Interactions between Metallothionein and Cisplatin by using Differential Pulse Voltammetry Brdickás reaction and Quartz Crystal Microbalance , 2009, Sensors.

[31]  S. Atrian,et al.  State-of-the-art of metallothioneins at the beginning of the 21st century , 2012 .

[32]  Vojtech Adam,et al.  Metallothionein – Immunohistochemical Cancer Biomarker: A Meta-Analysis , 2014, PloS one.

[33]  R. Lange,et al.  Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). , 1973, Cancer research.

[34]  J. Groten,et al.  Role of metallothionein in cisplatin sensitivity of germ‐cell tumours , 2000, International journal of cancer.

[35]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[36]  T. Matsuda,et al.  Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.

[37]  Celia Quevedo,et al.  Biochemical mechanisms of cisplatin cytotoxicity. , 2007, Anti-cancer agents in medicinal chemistry.

[38]  M. Cherian,et al.  Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells , 2004, Virchows Archiv A.

[39]  D. Gibson,et al.  Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles. , 2002, Journal of inorganic biochemistry.

[40]  A. Sigurdson,et al.  International patterns and trends in testis cancer incidence , 2005, International journal of cancer.

[41]  Petr Babula,et al.  Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours , 2012, International Journal of Electrochemical Science.